Concepedia

Thomas Q. de Aguiar Vallim

TQ

36

Publications

4.5K

Citations

29

H-Index

2008

Active since

Affiliations

University of California, Los Angeles(Current)

Ionis Pharmaceuticals (United States)

Monash University

Baker Heart and Diabetes Institute

University of California, Irvine

Thomas Q. de Aguiar Vallim is an author at University of California, Los Angeles specializing in medicine, biochemistry, and metabolism.

ORCID

Top concepts

Publications per year

2008–2023

36

Publications

36

Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation

Brian J. Bennett, Thomas Q. de Aguiar Vallim, Zeneng Wang et al. · Cell Metabolism · 2013 · 1K citations · Full text

, , +14

FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption

Bethan L. Clifford, Leslie R. Sedgeman, Kevin J. Williams et al. · Cell Metabolism · 2021 · 413 citations · Full text

, , +10

Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis

Diana M. Shih, Zeneng Wang, Richard Lee et al. · Journal of Lipid Research · 2014 · 328 citations · Full text

NOTCH1 is a mechanosensor in adult arteries

Julia J. Mack, Thiago Mosqueiro, Brian J. Archer et al. · Nature Communications · 2017 · 299 citations · Full text

Extracellular Matrix Remodeling Regulates Glucose Metabolism through TXNIP Destabilization

William J. Sullivan, Peter Mullen, E. Schmid et al. · Cell · 2018 · 258 citations · Full text

, , +5

Rows per page

1–5 of 36